Medtronic MDT reported second-quarterly earnings of $1.31 per share on Tuesday, which beat the analyst consensus estimate of $1.28 by 2.34%. This is a 7.38% increase over earnings of $1.22 per share from the same period last year.
The company reported quarterly sales of $7.706 billion, which beat the analyst consensus estimate of $7.66 billion by 0.60%. This is a 3.01% increase over sales of $7.481 billion the same period last year.
See Also: Barron's Picks And Pans: Medtronic, Tesla, Walmart And More
Medtronic raised fiscal year 2020 EPS guidance from $5.54-$5.60 to $5.57-$5.63 versus the $5.56 estimate.
Medtronic shares were trading up 2% at $113.50 in Tuesday’s pre-market session. The stock has a 52-week high of $114.46 and a 52-week low of $81.66.
Edge Rankings
Price Trend
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.